NASDAQ$QSI
Quantum-Si Inc · Q4 2022 earnings
Q4 2022 earnings · · Investor relations
Briefing
Quantum-Si reported financial results for Q4 2022, highlighted by the launch of Platinum and strategic partnerships.
Quantum-Si Incorporated reported a net loss of $33.14 million for the fourth quarter of 2022. The company launched Platinum, its benchtop protein sequencer, and executed multiple industry collaborations. They expect cash runway into 2026.
- Launched Platinum, the world’s first next-generation single-molecule protein sequencing system, in December 2022.
- Hired Grace Johnston, Ph.D. as Chief Commercial Officer and added key sales and market development personnel.
- Partnered with Aviva Systems Biology to co-develop sample preparation kits for protein sequencing research workflows with Platinum.
- Announced a partnership and license agreement with Biovista to integrate Biovista’s database and visualization technology into Quantum-Si’s Cloud analytics.
Headline financials
Revenue & EPS history
Quantum-Si · Revenue · Quarterly
$258K
Forward guidance
Quantum-Si plans to begin beta testing for CarbonTM in Q2 2023 and expects non-GAAP operating expenses to be approximately flat in 2023.
Tailwinds
- Begin beta testing for CarbonTM in Q2 2023.
- Launch CarbonTM in the second half of the year.
- Committed to preserving financial strength.
- Continue investments in R&D and commercialization.
- Expects non-GAAP operating expenses to be approximately flat in 2023.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2022
-4.1%
Avg return
Earnings day
-4.3%
Avg return
5 days after
+1.5%
Avg return
30 days after
39%
9 / 23 earnings
Positive
+14.5%
Q3 2023
Best reaction
-39.5%
Q2 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -4.5% | -8.3% | +1.0% | |
| Q4 2025 | -4.3% | -2.3% | -21.1% | |
| Q3 2025 | -8.5% | -12.2% | -20.0% | |
| Q1 2025 | +0.0% | -0.3% | +12.2% | |
| Q4 2024 | +6.2% | -0.8% | -10.8% | |
| Q3 2024 | -20.8% | -26.6% | +81.0% | |
| Q2 2024 | -2.8% | -4.8% | +4.5% | |
| Q1 2024 | -5.6% | +1.7% | -17.8% | |
| Q4 2023 | +6.3% | -7.5% | +13.2% | |
| Q3 2023 | +14.5% | +29.0% | +26.6% | |
| Q2 2023 | -39.5% | -34.8% | -31.9% | |
| Q1 2023 | -13.5% | -15.3% | -1.8% | |
| Q4 2022 | -12.5% | -26.4% | -27.8% | |
| Q3 2022 | +3.2% | +26.8% | -7.6% | |
| Q2 2022 | -6.0% | +9.7% | -14.4% | |
| Q1 2022 | -14.9% | -9.1% | +3.0% | |
| Q4 2019 | +6.2% | -3.8% | +12.5% | |
| Q4 2021 | +6.8% | -9.5% | +13.1% | |
| Q3 2021 | +1.2% | +1.4% | -21.5% | |
| Q2 2021 | +1.9% | +4.4% | +14.2% | |
| Q2 2020 | +1.9% | +4.4% | +14.2% | |
| Q1 2021 | -7.6% | -18.7% | +28.5% | |
| Q4 2020 | -1.1% | +5.0% | -13.8% | |
| Q3 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro